Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | ACHE | P22303 | 8/20 | 0.55 |
| ▸ | BCHE | P06276 | 6/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | GLA | P06280 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Tolyl Dimethylcarbamate SCHEMBL360147 | 0.91 | RAB9A (0.83) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| SCHEMBL9203037 | 0.89 | RAB9A (0.79) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| 4-Chlorophenyl Dimethylcarbamate SCHEMBL11300470 | 0.89 | RAB9A (0.79) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| SCHEMBL360146 | 0.89 | RAB9A (0.79) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| SCHEMBL15139541 | 0.89 | RAB9A (0.79) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| SCHEMBL9301148 | 0.89 | RAB9A (0.79) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| Phenyl Dimethylcarbamate SCHEMBL491227 | 0.88 | RAB9A (0.78) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| SCHEMBL28376845 | 0.87 | RAB9A (0.76) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| 4-Acetylphenyl Dimethylcarbamate SCHEMBL7185615 | 0.87 | RAB9A (0.76) | RAB9AKMT2ANPSR1GAAALDH1A1 | |
| SCHEMBL13774087 | 0.85 | RAB9A (0.73) | RAB9AKMT2ANPSR1GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6933403-B2 | Mono carbonylation of benzene diols | BIOLAND CO., LTD. (KR) | 2005-08-23 | — | — | US | disclosed |
| US-20040260114-A1 | Mono carbonylation of benzene diols | HYUNDAI BIOLAND CO., LTD. (KR) | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040260114-A1 | Mono carbonylation of benzene diols | CBR1, CBR3, CYP1A1 | RAB9A 3164/4885KMT2A 1893/4885NPSR1 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.